Discover 1,070 paid clinical trials in Ogden, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,070
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: Salt Lake City UT, Sacramento CA, Chandler AZ,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07276399
Phase3, Recruiting
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
for
Advanced Solid Tumors
Location: Salt Lake City UT, Rochester MN, St Louis MO,
Sponsor: Jacobio Pharmaceuticals Co., Ltd.
Sex: All
Age: 18+
Code: NCT06973564
Phase1, Phase2, Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Salt Lake City UT, Reno NV, Phoenix AZ, Eugene OR,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213804
Phase3, Recruiting
Impact of Intraoperative Oxygenation Practices on Patient Outcomes
for
Surgeries Undergoing General Anesthesia
Location: Salt Lake City UT, Omaha NE, Nashville TN
Sponsor: Frederic T Billings IV
Sex: All
Age: 18+
Code: NCT07224243
Recruiting
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
Get alerts for new trials in your area by subscribing now
Nurturing Exercise Routine for Greater Improvement in Zest and Energy on Enhertu
for
Metastatic Breast Cancer
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: All
Age: 18+
Code: NCT07203378
Phase2, Recruiting
SAVE Trial: SAfe Opioid Use Video Education
for
Breast Reconstruction, Breast Cancer
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: Female
Age: 18+
Code: NCT07044583
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Cancer, PDAC,
Location: Salt Lake City UT, Lakewood CO, Las Vegas NV,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07252232
Phase3, Recruiting
Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study
for
Breast Cancer
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: Female
Age: 18+
Code: NCT07029490
Recruiting
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Location: Salt Lake City UT, Wichita KS, Westwood KS,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT07190300
Phase1, Phase2, Recruiting
Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases
for
Bone Metastases
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: All
Age: 18+
Code: NCT07202273
Recruiting
Optimal PSA Triggered Individual Management of Androgen Sensitive Prostate Cancer
for
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: Male
Age: 18+
Code: NCT07216248
Phase2, Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Salt Lake City UT, Boise ID, Meridian ID, Nampa ID,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06876714
Phase3, Recruiting
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
for
Myeloproliferative Neoplasms
Location: Salt Lake City UT, Denver CO, Phoenix AZ, Palo Alto CA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07008118
Phase1, Recruiting
Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multiple Myeloma
for
Multiple Myeloma, Plasma Cell Leukemia
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: All
Age: 18+
Code: NCT06517017
Phase2, Recruiting
Ivosidenib as Post-HSCT Maintenance for AML
for
IDH1 Mutation, Acute Myeloid Leukemia (AML),
Location: Salt Lake City UT, Milwaukee WI, Columbus OH,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18 - 70+
Code: NCT06707493
Phase2, Recruiting
A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies
for
Solid Tumor Malignancies
Location: Salt Lake City UT, Denver CO, Los Angeles CA,
Sponsor: Kumquat Biosciences Inc.
Sex: All
Age: 18+
Code: NCT07207707
Phase1, Recruiting
Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies
for
Breast Cancer, Gynecologic Cancer
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: All
Age: 18+
Code: NCT07166042
Phase3, Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),
Location: Salt Lake City UT, Denver CO, Glendale AZ, Phoenix AZ,
Sponsor: Pfizer
Sex: Male
Age: 18+
Code: NCT07028853
Phase3, Recruiting
External Beam Radiotherapy Followed by Bispecific Antibody Therapy for Relapsed/Refractory DLBCL